Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

TE-Cooled MPPC Module

March 27, 2013 10:03 am | by MDT Staff | Hamamatsu Corp. | Product Releases | Comments

Hamamatsu Photonics introduce the new C11208 MPPC module which integrates the S11028 series MPPC, a pixelated silicon avalanche photodiode operated in Geiger-mode, with the addition of a high performance thermoelectric cooler.

Lyme Disease and Nanotubes, Paving Way for Diagnostic Device

March 27, 2013 9:45 am | by University of Pennsylvania | News | Comments

Early diagnosis is critical in treating Lyme disease. However, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection.

Trovagene Launches Urine-Based HPV Test

March 27, 2013 5:07 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , March 27, 2013 /- Trovagene, Inc. (NASDAQ:  TROV), today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus (HPV) test. The non-invasive test is designed to accurately identify the presence or absence of 15 known high-risk HPV strains using proprietary DNA sequences.

Advertisement

Guidance for Industry and Food and Drug Administration Staff - Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection of Antibodies to Borrelia burgdorferi

March 27, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

FDA is issuing this guidance to provide industry and agency staff with recommendations for studies to establish the analytical and clinical performance of in vitro diagnostic devices (IVDs) intended for the detection of antibodies to Borrelia burgdorferi.

More Light! – for Medicine

March 26, 2013 12:27 pm | by Forschungsverbund Berlin e.V. | News | Comments

PET scan, CT, and MRI are almost standard in today’s diagnostics – highly developed and very sophisticated. Although more capable and less cost-intensive, laser-optical diagnosis methods are, up to now, far less prevalent. FAMOS is aiming to change this.

Quinte Health Care Chooses Amcom Software for Critical Test Results Management

March 26, 2013 9:00 am | by The Associated Press | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Mar 26, 2013--Amcom Software, Inc. today announced Quinte Health Care (QHC) will use the Amcom® Critical Test Results Management (CTRM) solution to save time and improve patient safety and quality of care. The Ontario, Canada-based organization selected Amcom to...

UCLA Relies on Breakthrough ‘Big Data’ Technology from IBM To Help Patients with Traumatic Brain Injuries

March 25, 2013 11:20 pm | by IBM | News | Comments

IBM, and Excel Medical Electronics (EME) are collaborating with the UCLA Department of Neurosurgery in a study to test the effectiveness of a real-time alarm intended to predict rising brain pressure in patients with traumatic brain injuries. The experimental system uses big data analytics software developed by IBM Research and EME that analyzes in real-time streams of vital signs continuously collected from the bedside monitor...

OraQuick® Launches "Make Knowing Your Thing Today" Campaign to Promote the Importance of Knowing Your HIV Status

March 25, 2013 2:34 pm | by PR Newswire | News | Comments

LOS ANGELES, March 25, 2013 /PRNewswire/ -- OraSure Technologies, Inc. (NASDAQ:OSUR), maker of the OraQuick® In-Home HIV Test, announced today the launch of a nationwide awareness campaign to encourage everyone to learn their HIV status. The campaign, "Make Knowing Your...

Advertisement

FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients

March 22, 2013 7:07 pm | by The Associated Press | News | Comments

GE Healthcare today announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView™ (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s mortality risk.

Lantheus Medical Imaging Focuses on Growth, Takes Steps to Reduce Expenses

March 21, 2013 3:30 pm | by The Associated Press | News | Comments

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Mar 21, 2013--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that under its new leadership team led by Jeff Bailey, President and Chief Executive Officer,...

Leading U.S. Pulmonologists to Investigate Impact of Mauna Kea Technologies' Cellvizio on Lung Cancer Diagnosis

March 21, 2013 12:45 pm | by The Associated Press | News | Comments

Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that it has launched a registry study to determine the impact of Cellvizio optical biopsies on the diagnosis of lung cancer, the leading cause of cancer death in the world.

WPI and UMass Medical School Team Up to Improve Healthcare Delivery

March 21, 2013 11:22 am | by Worcester Polytechnic Institute | News | Comments

The Healthcare Delivery Institute is a multi-disciplinary organization that includes more than 20 research teams at WPI, external healthcare providers, and industry partners, all working to address the national and global challenge of creating the future of healthcare delivery.

Hologic's 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS

March 19, 2013 5:27 pm | by PR Newswire | News | Comments

BEDFORD, Mass., March 19, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced...

Advertisement

Douglas Harrington, MD Addresses Select Group of Physicians Regarding Latest Advances in Cardiovascular Risk Assessment

March 19, 2013 2:44 pm | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 19, 2013--Aviir Inc., a biotechnology company dedicated to enhanced detection and prevention of cardiovascular disease through innovative diagnostic tests, announced that Douglas Harrington, MD, Clinical Professor of Pathology at USC and Aviir, Inc. CEO,...

DiaTech Oncology Test Shows Improved Results, New Hope for Leukemia Patients

March 19, 2013 8:37 am | by The Associated Press | News | Comments

NASHVILLE, Tenn.--(BUSINESS WIRE)--Mar 19, 2013--Results of clinical trials published this month in the medical peer-review journal showed overall survival rate improved 257% for certain groups of leukemia patients when physicians used DiaTech Oncology’s test to help determine chemotherapy...

Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders

March 18, 2013 1:07 pm | by Bio-Medicine.Org | News | Comments

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available...

Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and Quantstudio(TM) DX and 7500 Fast DX Real-Time PCR Instruments

March 18, 2013 8:00 am | by The Associated Press | News | Comments

Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that they received 510(k) clearances from the United States Food and Drug Administration (FDA) to market the Quidel Molecular Direct C. difficile Assay with Life Technologies'...

Pathwork Diagnostics Collaborating with Kindstar Global to Provide Tissue of Origin Test in China

March 14, 2013 11:00 am | by The Associated Press | News | Comments

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar 14, 2013--Pathwork Diagnostics, Inc., the innovator of the Pathwork Tissue of Origin Test and a pioneer in creating genomics-based diagnostics in oncology, announced today that it has entered into an agreement with Kindstar Global (Kindstar) to provide...

Atossa Genetics Announces National Agreement With Network Provider FedMed

March 13, 2013 8:30 am | by The Associated Press | News | Comments

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has entered into a contractual agreement with FedMed, Inc., one of the largest proprietary Preferred Provider Organization (PPO) networks in the U.S., for diagnostic laboratory testing. FedMed's network is...

NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of Korea

March 12, 2013 7:00 am | by The Associated Press | News | Comments

WALTHAM, Mass.--(BUSINESS WIRE)--Mar 12, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has entered an agreement with Handok Pharmaceuticals, Inc. Under terms of the agreement,...

University of Texas Health Science Center at Houston Releases News of Successful NanoLogix Test

March 12, 2013 1:38 am | by The Associated Press | News | Comments

UTHealth researchers say more rapid test for Group B strep successful NanoLogix Inc. (OTC: NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria, announces that final results of a 14 month study done by researchers at UTHSC-Houston have been published in a recent online edition of “ Infectious Diseases in Obstetrics and Gynecology.”

Screening for BNP & Targeted Care Reduce Heart Failure in At-Risk Patients

March 11, 2013 5:52 pm | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 11, 2013--Alere Inc. (NYSE: ALR) is pleased to announce the results of research presented at today’s American College of Cardiology’s 62nd Annual Scientific Session, which showed that a simple screening and management program can be effective in preventing heart...

Designers, Hackers, Healers, & Hustlers Tackle Employee Wellness in Innovation Challenge

March 11, 2013 4:50 pm | by Ryan Wynia, Founder|Design Visioneer, FIREBONE | Articles | Comments

The innovators selected to participate in StartX MedIC were unbelievable individuals. The participants included physicians, surgeons, physicists, electrical engineers, mechanical engineers, computer scientists, data scientists, computer programmers, industrial designers, interface designers, interaction designers, start-up founders, serial entrepreneurs, inventors, PhD students, medical students, and marketing executives from all types organizations and institutions.

Data Presented at ACC 2013 Confirms Use of Corus@ CAD in Women with Suspected Obstructive Coronary Artery Disease Influences Patient Management Decisions

March 11, 2013 8:31 am | by The Associated Press | News | Comments

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a prospective study that evaluated how Corus@ CAD, a blood-based gene expression test, influenced cardiologists' patient management decisions in women with suspected obstructive coronary...

NovaSom is AASM’s First Approved Out of Center Sleep Test Provider

March 11, 2013 8:04 am | by The Associated Press | News | Comments

GLEN BURNIE, Md.--(BUSINESS WIRE)--Mar 11, 2013--NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announced it has been recognized by the American Academy of Sleep Medicine (AASM) as the first Approved Out of Center Sleep...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading